Daily aspirin for prevention of death from MI unwarranted in most people
Interviewed by Steven Greer, MD
For decades, doctors have recommended daily aspiring to prevent death from myocardial infarction to patients with certain risk factors other than previous MI (i.e. primary prevention). However, numerous randomized trials have been adding to the mounting evidence that the serious bleeding risks from aspirin outweigh the benefits. Dr. Kausik Ray from St. George’s University of London was an author of the latest meta-analysis of these trials, and discusses the findings.
(In full screen 1080i HD)
Cardiology/medicine, Hematology, Late Breaking Data, Neurology, Preventive Medicine, St George's Univ London | apples49 | 
June 14, 2012 3:59 pm
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI
